Abstract:Inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) is one of important kinases in inflammation to phosphorylate inhibitor of nuclear factor kappa-B (IκBα) and then activate nuclear factor kappa-B (NF-κB). Inhibition of IKKβ has been a therapeutic strategy for inflammatory and autoimmune diseases. Here we report that IKKβ is constitutively activated in healthy donors and healthy Ikkβ C46A (cysteine 46 mutated to alanine) knock-in mice although they possess intensive IKKβ-IκBα-NF-κB signaling activation. These indicate that IKKβ activation probably plays homeostatic role instead of causing inflammation. Compared to Ikkβ WT littermates, lipopolysaccharides (LPS) could induce high mortality rate in Ikkβ C46A mice which is correlated to breaking the homeostasis by intensively activating p-IκBα-NF-κB signaling and inhibiting phosphorylation of 5' adenosine monophosphate-activated protein kinase (p-AMPK) expression. We then demonstrated that IKKβ kinase domain (KD) phosphorylates AMPKα1 via interacting with residues Thr183, Ser184, and Thr388, while IKKβ helix-loop-helix motifs is essential to phosphorylate IκBα according to the previous reports. Kinase assay further demonstrated that IKKβ simultaneously catalyzes phosphorylation of AMPK and IκBα to mediate homeostasis. Accordingly, activation of AMPK rather than inhibition of IKKβ could substantially rescue LPS-induced mortality in Ikkβ C46A mice by rebuilding the homeostasis. We conclude that IKKβ activates AMPK to restrict inflammation and IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBα.

IKIP Negatively Regulates NF-κB Activation and Inflammation Through Inhibition of IKKα/β Phosphorylation

A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation.

A Negative Feedback Loop of ICER and NF-κB Regulates TLR Signaling in Innate Immune Responses

NF-κB is a Negative Regulator of IL-1β Secretion As Revealed by Genetic and Pharmacological Inhibition of IKKβ

NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta

The Inhibitor Effect of RKIP on Inflammasome Activation and Inflammasome-Dependent Diseases

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

Raf Kinase Inhibitor Protein Preferentially Promotes Tlr3-Triggered Signaling and Inflammation

IκB Kinase is an Essential Component of the Tpl2 Signaling Pathway

IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBα

NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK

IKKϵ Negatively Regulates RIG‐I Via Direct Phosphorylation

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

A New Way to Regulate Inflammation: Selective Autophagic Degradation of IKKγ Mediated by ANGPTL8.

The 11S Proteasome Subunit PSME3 is a Positive Feedforward Regulator of NF-κB and Important for Host Defense Against Bacterial Pathogens.

Regulation of IκBα Expression Involves Both NF-κB and the MAP Kinase Signaling Pathways

A new way to regulate inflammation: selective autophagic degradation of IKK gamma mediated by ANGPTL8

Hcinap Negatively Regulates NF-κB Signaling by Recruiting the Phosphatase PP1 to Deactivate IKK Complex.

Selective Regulation of a Defined Subset of Inflammatory and Immunoregulatory Genes by an NF-κB p50-IκBζ Pathway

Mechanism of Negative Regulation of NF-κB by N4BP1

Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ